Contralateral prophylactic mastectomy for patients with unilateral breast cancer - Wikidata - awgldk - TriplyDB

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

http://www.wikidata.org/entity/Q23922906

about

Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast.Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status.Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).Current surgery for breast cancer.Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California.

P2860

Q33926134-C76A94BF-233C-43FD-8F5B-FFCEE48F7DE7 Q34358066-968761BC-2493-4433-B8E8-8D60440A4EFA Q35073191-30896671-32D6-44F1-B5FB-CD21CD5F8E52 Q35115896-43F33647-AFFC-469F-918D-7DB202863DA5 Q35120228-BBCAC7BC-0B88-4EE4-AE26-0BCC677FFFED Q35192288-37AFDDA6-3001-4FBB-9C45-D9C10BFA25FA Q35692061-91569EC6-46CF-4165-875A-9F25EAC72F55 Q36265582-19A2B18B-8F1E-4F17-8601-A27EAC269DC9 Q36436637-4A5CE724-0232-41BE-92E7-91122D17D09A Q37151892-4E368BE3-1763-4C41-91B0-92352C216790 Q37267678-DD302F83-9A0B-42F5-AC1B-B5D42131D180 Q37486768-1DD36496-5B39-421C-A1B4-61B65ABA5FA2 Q42924780-CF3F0AB0-4505-4806-90A0-DEEBAEC86D3C

P2860

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

http://www.wikidata.org/entity/Q23922906

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@ast

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@en

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@en-gb

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@nl

type

label

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@ast

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@en

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@en-gb

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@nl

prefLabel

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@ast

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@en

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@en-gb

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@nl

P1433

Q23922906-9CC52E83-BBCB-4AD1-A377-646BDE7DF94F

P1476

Q23922906-35CCE8E6-850E-45E0-ACCF-097E20A277DC

P2093

Q23922906-33DE1DC0-FE27-492A-931A-C465BAFED8CD

Q23922906-35C3E687-1673-4D11-9EF0-90E11111C64B

Q23922906-5F367BFC-81D4-4C56-B63F-1ACEC9390B1E

Q23922906-F1317DA7-5A30-4D3A-8B79-FC8E218CBB3A

P2860

Q23922906-19E14A13-DEB3-4F9D-BF4F-33830EAF09D5

Q23922906-2AF92964-B3F6-4A36-9218-3E77EB1CB7FB

Q23922906-455866F7-DE87-487D-8096-B35993ED173E

Q23922906-4D5D9D8C-2B73-442D-A404-D2C2C0CF2318

Q23922906-55FDF828-A93C-4207-B4DF-506B1DDC744D

Q23922906-5A69C917-519A-4D1B-B200-10D98840818C

Q23922906-64BB3560-E4C9-45DE-82A7-21A2791B7519

Q23922906-7E09374C-7154-4E5F-842B-CDD8CB641A2B

Q23922906-8DEDEC29-76A6-47CE-9A8F-E1BFEAABE0AF

Q23922906-956136E7-9C30-4CA2-BB43-9F9F6142F816

P2880

Q23922906-3AD05079-AEBC-4660-A8B6-BE05FDE0F6C4

P304

Q23922906-AC1FDF6D-F6AC-4993-A566-725850A43D37

P31

Q23922906-3B6A173A-C66C-4F9C-A895-DCF56EA12097

P3181

Q23922906-1F9781DD-BEF0-49EB-8C6B-2AAD35C745A2

P356

Q23922906-D96F2594-155C-4F18-A004-903412B76A54

P433

Q23922906-856C6678-A217-4168-922F-D4846B46057B

P478

Q23922906-F5D62796-79E9-4F91-A3E2-D5E897DD00D0

P50

Q23922906-81A075A6-6291-4C05-851C-35BAE40CF2EB

P577

Q23922906-4B514C88-7B21-4B48-BAF5-13C0511DC580

P5875

Q23922906-05E155C5-CB97-4FEE-8C02-4057A2814FE9

P698

Q23922906-77AE2580-CDA5-4D0B-A912-5213946245D6

P859

Q23922906-A70FA37F-E1F4-4D0A-B4D9-0B1F3B36A1B0

P921

Q23922906-08D75133-C33B-40F8-8BAD-750F3DBC5DEA

Q23922906-12986295-1725-4F44-9F2C-A5BA56525F24

Q23922906-12CF154B-B612-4999-9396-CDF26E7F9681

Q23922906-74683C73-6091-4D13-8303-5BDF02B443B5

Q23922906-975F49AA-F2AE-4B5C-BF9C-66C7C11199B4

Q23922906-A2C6FCD9-ABA3-40BE-97CA-F8E665B2FC4D

Q23922906-DE94B755-71F1-4689-B695-24EF6AF0481A

P3181

P356

14737140.7.8.1117

P1433

Expert Review of Anticancer Therapy

P1476

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

@en

P2093

Anasooya Abraham

http://www.w3.org/2001/XMLSchema#string

Beth Virnig

http://www.w3.org/2001/XMLSchema#string

Timothy Emory

http://www.w3.org/2001/XMLSchema#string

Todd Tuttle

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?

Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging.

Contralateral prophylactic mastectomy. Predictors of significant histologic findings.

Risk of contralateral breast cancer in Denmark 1943-80.

The incidence of bilateral breast cancer: II. A proposed model for the analysis of coincidental tumours

Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

P2880

20037551

http://www.w3.org/2001/XMLSchema#string

P304

1117-1122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3447047

http://www.w3.org/2001/XMLSchema#string

P356

10.1586/14737140.7.8.1117

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth B Habermann

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5819358

http://www.w3.org/2001/XMLSchema#string

P698

18028020

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

reproductive health

exposure assessment